Up-date on diagnostic strategies of invasive aspergillosis
M Lackner, C Lass-Florl - Current pharmaceutical design, 2013 - ingentaconnect.com
Invasive fungal infections are a major cause of morbidity and mortality in
immunosuppressed patients with fatality rates ranging from 30% to 80% in neutropenic …
immunosuppressed patients with fatality rates ranging from 30% to 80% in neutropenic …
Update on invasive aspergillosis: clinical and diagnostic aspects
Apergillus is a ubiquitious mould that can cause a wide variety of clinical syndromes ranging
from mere colonisation to fulminant invasive disease. Invasive aspergillosis (IA) is the most …
from mere colonisation to fulminant invasive disease. Invasive aspergillosis (IA) is the most …
Diagnosis of invasive aspergillosis: recent developments and ongoing challenges
M Arvanitis, E Mylonakis - European Journal of Clinical …, 2015 - Wiley Online Library
Background Invasive aspergillosis is an infection with high morbidity and mortality that
affects mostly immunocompromised individuals. Early identification and targeted treatment …
affects mostly immunocompromised individuals. Early identification and targeted treatment …
Diagnosing invasive fungal diseases–limitations of microbiological diagnostic methods
C Lass-Flörl, A Mayr - Expert Opinion on Medical Diagnostics, 2009 - Taylor & Francis
Background: Invasive fungal infections (IFD) are a principal cause of morbidity and mortality
in immunosuppressed patients, with case fatality rates ranging from 30–80% in neutropenic …
in immunosuppressed patients, with case fatality rates ranging from 30–80% in neutropenic …
Laboratory diagnosis of invasive aspergillosis: from diagnosis to prediction of outcome
RC Barton - Scientifica, 2013 - Wiley Online Library
Invasive aspergillosis (IA), an infection caused by fungi in the genus Aspergillus, is seen in
patients with immunological deficits, particularly acute leukaemia and stem cell …
patients with immunological deficits, particularly acute leukaemia and stem cell …
[HTML][HTML] Aspergillosis: an update on clinical spectrum, diagnostic schemes, and management
R Kanaujia, S Singh, SM Rudramurthy - Current Fungal Infection Reports, 2023 - Springer
Abstract Purpose of Review This review gives an overview of the diseases caused by
Aspergillus, including a description of the species involved and the infected clinical systems …
Aspergillus, including a description of the species involved and the infected clinical systems …
The current management landscape: aspergillosis
JA Maertens, O Blennow, RF Duarte… - Journal of Antimicrobial …, 2016 - academic.oup.com
Diagnosing invasive aspergillosis (IA) has long been challenging due to the inability to
culture the causal Aspergillus agent from blood or other body fluids. This shortcoming has …
culture the causal Aspergillus agent from blood or other body fluids. This shortcoming has …
Current challenges in the microbiological diagnosis of invasive aspergillosis
J Guinea, E Bouza - Mycopathologia, 2014 - Springer
The diagnosis of invasive aspergillosis is challenging because no sufficiently sensitive or
specific tests have been developed to date. Infection can only be confirmed using histology …
specific tests have been developed to date. Infection can only be confirmed using histology …
The use of biomarkers and molecular methods for the earlier diagnosis of invasive aspergillosis in immunocompromised patients
A Ambasta, J Carson, DL Church - Medical mycology, 2015 - academic.oup.com
Invasive aspergillosis (IA) is an opportunistic infection that is often life threatening in the
immunocompromised host. Early diagnosis is critical, especially given the efficacy and …
immunocompromised host. Early diagnosis is critical, especially given the efficacy and …
Defining the diagnosis of invasive aspergillosis
G Chamilos, DP Kontoyiannis - Medical Mycology, 2006 - academic.oup.com
Invasive aspergillosis (IA) is a leading cause of death in severely immunocompromised
patients. Delayed diagnosis remains a major impediment to successful treatment of IA …
patients. Delayed diagnosis remains a major impediment to successful treatment of IA …